Celiac Disease
Find information on Celiac Disease diagnosis, including clinical documentation, medical coding, and healthcare guidance. Learn about gluten-sensitive enteropathy, coeliac disease, and non-tropical sprue, focusing on symptoms, testing, and treatment options. This resource offers valuable insights for healthcare professionals and patients seeking information on Celiac Disease management and coding best practices.
Autoimmune disorder triggered by gluten ingestion, damaging the small intestine.
Diarrhea, bloating, abdominal pain, weight loss, fatigue. Dermatitis herpetiformis can occur.
Primary care, gastroenterology, pediatrics. Diagnosis via blood tests, endoscopy.
ICD-10 Code Families
Complete code families applicable to K90.0
When to use each related code
| Description | When to use |
|---|---|
| Autoimmune reaction to gluten. | Diagnosed by biopsy showing villous atrophy. Use when gluten causes digestive symptoms and other related issues. |
| Gluten sensitivity without the autoimmune component of Celiac Disease. | Consider if gluten causes symptoms, but celiac tests are negative. Exclude wheat allergy. |
| Allergic reaction to wheat protein, often rapid onset. | Use when wheat ingestion causes immediate symptoms like hives, itching, or anaphylaxis. IgE testing can confirm. |
Best-practice checklist
- ✓Celiac Disease (C) diagnosis: document symptoms, e.g., diarrhea, bloating
- ✓Celiac Disease: record serology (tTG-IgA, EMA, DGP IgA/IgG) results
- ✓Celiac Disease: note endoscopic findings (e.g., scalloping, villous atrophy)
- ✓Celiac Disease: include genetic testing (HLA-DQ2/DQ8) if performed
- ✓Document dietary history and response to gluten-free diet
Common pitfalls to avoid
Using only the unspecified celiac code (K90.0) without documenting the specific type (e.g., K90.81 for refractory celiac) leads to inaccurate severity reflection and reimbursement.
Coding celiac disease as confirmed when it's only suspected (R76.11) is improper until definitive diagnosis is made through biopsy, leading to denial of claims.
Failing to code related manifestations like dermatitis herpetiformis (L13.0) or anemia (D50-D64) with celiac can result in incomplete clinical picture and lower reimbursement.
Best-practice tips
- 01Code K90.0 for Celiac Disease, ensuring proper ICD-10-CM coding.
- 02Document gluten-free diet adherence for Celiac Disease management.
- 03Query for specific Celiac symptoms like diarrhea and abdominal pain.
- 04Screen for associated conditions like dermatitis herpetiformis and anemia.
- 05Monitor growth and development in pediatric Celiac Disease patients.
Step-by-step checklist
- 1
1. Confirm gluten exposure and symptoms (ICD-10 K90.0)
- 2
2. Order serological tests (tTG-IgA, EMA-IgA): document rationale
- 3
3. Consider genetic testing (HLA-DQ2/DQ8) if serology positive
- 4
4. If tests positive, refer for endoscopic biopsy for confirmation
- 5
5. Document diagnosis, management plan, and patient education
Ready-to-paste narrative
Patient presents with symptoms suggestive of celiac disease, including chronic diarrhea, abdominal pain, bloating, and weight loss. The patient reports experiencing these symptoms intermittently for the past six months, with exacerbations following the ingestion of gluten-containing foods such as bread, pasta, and beer. Family history is positive for autoimmune disorders, increasing the suspicion for celiac disease. Physical examination reveals abdominal distension and tenderness. Differential diagnosis includes irritable bowel syndrome, inflammatory bowel disease, and lactose intolerance. To confirm the diagnosis of celiac disease, serological testing for tissue transglutaminase IgA antibodies and endomysial antibodies will be performed. If serology is positive, an esophagogastroduodenoscopy with small bowel biopsy is indicated to assess for villous atrophy and confirm the diagnosis histologically. Depending on the diagnostic findings, the patient will be counseled on the importance of strict adherence to a gluten-free diet. Dietary management education, including guidance on gluten-free food choices and hidden sources of gluten, will be provided. Follow-up appointments will be scheduled to monitor symptom resolution, nutritional status, and adherence to the gluten-free diet. ICD-10 code K90.0 will be used for celiac disease. Long-term monitoring will be necessary to assess for complications of celiac disease such as anemia, osteoporosis, and small bowel lymphoma. Patient education materials on celiac disease, gluten-free diet resources, and support groups will be provided.
Common questions and answers
What are the most specific and sensitive serological tests for diagnosing celiac disease in adults presenting with atypical symptoms?+
While tissue transglutaminase IgA (tTG-IgA) is often the first-line serological test for celiac disease, its sensitivity can be reduced in patients with IgA deficiency. For adults presenting with atypical symptoms like fatigue, iron-deficiency anemia, or osteoporosis, consider adding endomysial antibody (EMA) testing and total IgA levels. EMA has high specificity, and testing for IgA deficiency ensures accurate interpretation of tTG-IgA results. If IgA deficiency is present, IgG-based serological tests like tTG-IgG or deamidated gliadin peptide IgG (DGP-IgG) should be used. A combination of serological tests often provides the most comprehensive assessment, especially in complex presentations. Explore how different serological markers contribute to diagnostic accuracy in celiac disease.
How can I differentiate between celiac disease, non-celiac gluten sensitivity (NCGS), and irritable bowel syndrome (IBS) in clinical practice when symptoms overlap?+
Overlapping symptoms like abdominal pain, bloating, and altered bowel habits can make distinguishing between celiac disease, NCGS, and IBS challenging. Serological testing (tTG-IgA, EMA) and duodenal biopsy are crucial for confirming celiac disease. If serology is negative and celiac disease is ruled out, consider a trial of a gluten-free diet. Improvement in symptoms suggests NCGS, but it's important to note that this diagnosis is based on symptom response and lacks specific biomarkers. If symptoms persist despite a gluten-free diet, investigate for IBS using Rome IV criteria and consider further testing to exclude other gastrointestinal disorders. Learn more about the diagnostic criteria and management strategies for differentiating these overlapping conditions.
What are the recommended follow-up guidelines and monitoring strategies for patients with confirmed celiac disease, particularly regarding long-term complications?+
After diagnosis of celiac disease, strict adherence to a gluten-free diet is paramount. Regular follow-up is crucial to monitor symptomatic response, nutritional status (iron, vitamin B12, folate, vitamin D), and adherence to the diet. Patients should be monitored for persistent symptoms or development of new complications, such as refractory celiac disease, enteropathy-associated T-cell lymphoma, or osteoporosis. Repeat serological testing can be helpful to assess dietary adherence, although it's not always a perfect indicator. Consider implementing a multidisciplinary approach involving a dietitian and gastroenterologist for optimal long-term management and to address the risk of long-term complications. Explore how ongoing monitoring and patient education contribute to improved outcomes in celiac disease management.
Clinical accuracy: This information is provided for documentation and coding guidance and should not replace professional medical judgment.
Coding standard: ICD-10-CM, current FY guidelines.